Connection

Eric Rovner to Female

This is a "connection" page, showing publications Eric Rovner has written about Female.
Connection Strength

1.706
  1. Update on Urethral Bulking for Stress Urinary Incontinence in Women. Curr Urol Rep. 2022 Oct; 23(10):203-209.
    View in: PubMed
    Score: 0.045
  2. Is it the Surgeon? A Re-examination of Mid-urethral Sling Complications. Urology. 2021 11; 157:269-273.
    View in: PubMed
    Score: 0.043
  3. Urinary retention after AdVance? Sling: A multi-institutional retrospective study. Neurourol Urodyn. 2021 01; 40(1):515-521.
    View in: PubMed
    Score: 0.041
  4. Do urodynamics predict urinary retention after sling placement in the complex patient: the value of reproducing symptoms on urodynamics. Int Urogynecol J. 2021 Jan; 32(1):81-86.
    View in: PubMed
    Score: 0.041
  5. Is polypropylene mesh material fundamentally safe for use as a reconstructive material in vaginal surgery: ICI-RS 2019? Neurourol Urodyn. 2020 07; 39 Suppl 3:S132-S139.
    View in: PubMed
    Score: 0.038
  6. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020 02; 39(2):744-753.
    View in: PubMed
    Score: 0.038
  7. One-year results with selective bladder denervation in women with refractory overactive bladder. Neurourol Urodyn. 2019 11; 38(8):2178-2184.
    View in: PubMed
    Score: 0.037
  8. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
    View in: PubMed
    Score: 0.036
  9. A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology. Contemp Clin Trials. 2018 07; 70:83-87.
    View in: PubMed
    Score: 0.034
  10. Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon. Neurourol Urodyn. 2018 01; 37(1):440-448.
    View in: PubMed
    Score: 0.033
  11. Outcomes of treatment of stress urinary incontinence associated with female urethral diverticula: A selective approach. Neurourol Urodyn. 2018 01; 37(1):478-484.
    View in: PubMed
    Score: 0.032
  12. Transvaginal approach to distal ureterectomy in an obstructed remnant. Int Urogynecol J. 2017 Sep; 28(9):1431-1433.
    View in: PubMed
    Score: 0.032
  13. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Low Urin Tract Symptoms. 2018 Sep; 10(3):221-230.
    View in: PubMed
    Score: 0.032
  14. Analysis of Complications of Pelvic Mesh Excision Surgery Using the Clavien-Dindo Classification System. J Urol. 2017 09; 198(3):638-643.
    View in: PubMed
    Score: 0.032
  15. Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications. Neurourol Urodyn. 2017 04; 36(4):1155-1160.
    View in: PubMed
    Score: 0.030
  16. Lower urinary tract symptoms in women: epidemiology, diagnosis, and management. Curr Opin Urol. 2016 07; 26(4):328-33.
    View in: PubMed
    Score: 0.030
  17. A case of uncomplicated urinary myiasis in a healthy female. BMJ Case Rep. 2016 Jun 23; 2016.
    View in: PubMed
    Score: 0.030
  18. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8.
    View in: PubMed
    Score: 0.030
  19. Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the "3Ds" Still Relevant? Urology. 2016 Aug; 94:53-6.
    View in: PubMed
    Score: 0.029
  20. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal. J Urol. 2016 Aug; 196(2):484-9.
    View in: PubMed
    Score: 0.029
  21. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Urology. 2016 05; 91:46-51.
    View in: PubMed
    Score: 0.029
  22. New treatments for incontinence. Adv Chronic Kidney Dis. 2015 Jul; 22(4):279-88.
    View in: PubMed
    Score: 0.028
  23. Removal of Polypropylene Sling Mesh From the Urethra: An Anatomic Technique. Urology. 2015 Jul; 86(1):196-9.
    View in: PubMed
    Score: 0.028
  24. Simple vs complex urethral diverticulum: presentation and outcomes. Urology. 2014 Dec; 84(6):1516-9.
    View in: PubMed
    Score: 0.027
  25. Patient perception of transvaginal mesh and the media. Urology. 2014 Sep; 84(3):575-82.
    View in: PubMed
    Score: 0.026
  26. Management of failed stress urinary incontinence surgery. Curr Urol Rep. 2014 Aug; 15(8):429.
    View in: PubMed
    Score: 0.026
  27. Implications of the FDA statement on transvaginal placement of mesh: the aftermath. Curr Urol Rep. 2014 Feb; 15(2):380.
    View in: PubMed
    Score: 0.025
  28. A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol. 2013 Dec; 190(6):2243-50.
    View in: PubMed
    Score: 0.024
  29. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2013 Nov; 32(8):1109-15.
    View in: PubMed
    Score: 0.024
  30. Sling location in women with recurrent stress urinary incontinence following midurethral sling. Urology. 2012 Jan; 79(1):76-9.
    View in: PubMed
    Score: 0.022
  31. Transvaginal bladder neck closure with posterior urethral flap for devastated urethra. Urology. 2011 Jul; 78(1):208-12.
    View in: PubMed
    Score: 0.021
  32. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn. 2011 Apr; 30(4):556-62.
    View in: PubMed
    Score: 0.021
  33. Predicting for postoperative incontinence following sling incision. Int Urogynecol J. 2011 Jun; 22(6):665-9.
    View in: PubMed
    Score: 0.020
  34. An update on surgery for pelvic organ prolapse. Curr Opin Urol. 2010 Nov; 20(6):490-4.
    View in: PubMed
    Score: 0.020
  35. Stress incontinence surgery: which operation when? Curr Opin Urol. 2009 Jul; 19(4):362-7.
    View in: PubMed
    Score: 0.018
  36. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93.
    View in: PubMed
    Score: 0.017
  37. Adherence to the 1997 American Urological Association guidelines for the surgical treatment of stress urinary incontinence. Urology. 2008 Feb; 71(2):239-42.
    View in: PubMed
    Score: 0.017
  38. Complications of anterior compartment vaginal surgery. Curr Urol Rep. 2007 Sep; 8(5):405-12.
    View in: PubMed
    Score: 0.016
  39. Urethral diverticula: a review and an update. Neurourol Urodyn. 2007; 26(7):972-7.
    View in: PubMed
    Score: 0.015
  40. Vaginal erosion after hybrid midurethral sling placement. Urology. 2006 Dec; 68(6):1343.e13-4.
    View in: PubMed
    Score: 0.015
  41. Trospium chloride: the European experience. Expert Opin Pharmacother. 2006 Jul; 7(10):1373-80.
    View in: PubMed
    Score: 0.015
  42. Female urethral strictures: successful management with long-term clean intermittent catheterization after urethral dilatation. BJU Int. 2006 Jul; 98(1):96-9.
    View in: PubMed
    Score: 0.015
  43. Long-term chronic complications from Stamey endoscopic bladder neck suspension: a case series. Int Urogynecol J Pelvic Floor Dysfunct. 2006 May; 17(3):290-4.
    View in: PubMed
    Score: 0.014
  44. Bone anchors for stress urinary incontinence in 2004: con. Urology. 2004 Nov; 64(5):851-4.
    View in: PubMed
    Score: 0.013
  45. Pharmacologic management of urinary incontinence in the female. Minerva Ginecol. 2004 Aug; 56(4):327-47.
    View in: PubMed
    Score: 0.013
  46. Urodynamically defined stress urinary incontinence and bladder outlet obstruction coexist in women. J Urol. 2004 Feb; 171(2 Pt 1):757-60; discussion 760-1.
    View in: PubMed
    Score: 0.013
  47. Trospium chloride in the management of overactive bladder. Drugs. 2004; 64(21):2433-46.
    View in: PubMed
    Score: 0.013
  48. Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol. 2003 Jul; 170(1):82-6; discussion 86.
    View in: PubMed
    Score: 0.012
  49. Evaluation of lower urinary tract symptoms in females. Curr Opin Urol. 2003 Jul; 13(4):273-8.
    View in: PubMed
    Score: 0.012
  50. Vaginal erosion after pubovaginal sling procedures using dermal allografts. J Urol. 2003 Jan; 169(1):286-7.
    View in: PubMed
    Score: 0.012
  51. Definition and epidemiology of overactive bladder. Urology. 2002 Nov; 60(5 Suppl 1):7-12; discussion 12.
    View in: PubMed
    Score: 0.012
  52. Pharmacologic management of urinary incontinence in women. Urol Clin North Am. 2002 Aug; 29(3):537-50, viii.
    View in: PubMed
    Score: 0.011
  53. Does urinary urgency drive urinary frequency in overactive bladder? Low Urin Tract Symptoms. 2022 Jul; 14(4):242-247.
    View in: PubMed
    Score: 0.011
  54. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol. 2002 Jan; 41(1):6-14.
    View in: PubMed
    Score: 0.011
  55. Severe urinary tract damage secondary to primary bladder neck obstruction in women. PLoS One. 2021; 16(3):e0248938.
    View in: PubMed
    Score: 0.010
  56. Urinary fistula between the bladder and lower extremity following Burch urethropexy. J Urol. 2001 Feb; 165(2):525-6.
    View in: PubMed
    Score: 0.010
  57. Significance of hematuria in patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology. 2001 Feb; 57(2):262-5.
    View in: PubMed
    Score: 0.010
  58. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology. 2000 Dec 20; 56(6):940-5.
    View in: PubMed
    Score: 0.010
  59. Pelvic organ prolapse: a review. Ostomy Wound Manage. 2000 Dec; 46(12):24-37.
    View in: PubMed
    Score: 0.010
  60. Angiomyolipoma of the renal sinus: diagnosis by percutaneous biopsy. Urology. 2000 Feb; 55(2):286.
    View in: PubMed
    Score: 0.010
  61. Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents. J Vis Exp. 2020 01 31; (155).
    View in: PubMed
    Score: 0.010
  62. Ventral hernia of the urinary bladder with mixed urinary incontinence: treatment with herniorrhaphy and allograft fascial sling. Urology. 2000 Jan; 55(1):145.
    View in: PubMed
    Score: 0.010
  63. Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). Adv Ther. 2019 08; 36(8):1906-1921.
    View in: PubMed
    Score: 0.009
  64. Extraperitoneal laparoscopic urethropexy with Marlex mesh. Urology. 1999 May; 53(5):985-9.
    View in: PubMed
    Score: 0.009
  65. Images in clinical urology. Magnetic resonance imaging of a "saddle bag" urethral diverticulum. Urology. 1999 Apr; 53(4):818-9.
    View in: PubMed
    Score: 0.009
  66. The overactive bladder: an overview for primary care health providers. Int J Fertil Womens Med. 1999 Mar-Apr; 44(2):56-66.
    View in: PubMed
    Score: 0.009
  67. Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder. J Urol. 2019 03; 201(3):573-580.
    View in: PubMed
    Score: 0.009
  68. Surgery for urinary incontinence in women: Report from the 6th international consultation on incontinence. Neurourol Urodyn. 2019 02; 38(2):825-837.
    View in: PubMed
    Score: 0.009
  69. Study design and outcomes measures: The influence of composite endpoints and other design variables on outcomes in a study of a novel device for stress urinary incontinence. Neurourol Urodyn. 2018 11; 37(8):2919-2927.
    View in: PubMed
    Score: 0.009
  70. Why anti-incontinence surgery succeeds or fails. Clin Obstet Gynecol. 1998 Sep; 41(3):719-34.
    View in: PubMed
    Score: 0.009
  71. Re: Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. J Urol. 1998 May; 159(5):1646-7.
    View in: PubMed
    Score: 0.008
  72. Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon. Female Pelvic Med Reconstr Surg. 2018 May/Jun; 24(3):222-231.
    View in: PubMed
    Score: 0.008
  73. Primary slings for everyone with genuine stress incontinence? The argument against. Int Urogynecol J 1997,8:321-322. Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9(6):419.
    View in: PubMed
    Score: 0.008
  74. A method for intraoperative adjustment of sling tension: prevention of outlet obstruction during vaginal wall sling. Urology. 1997 Aug; 50(2):273-6.
    View in: PubMed
    Score: 0.008
  75. Nongenomic modulation of the large conductance voltage- and Ca2+-activated K+ channels by estrogen: A novel regulatory mechanism in human detrusor smooth muscle. Physiol Rep. 2017 Jul; 5(14).
    View in: PubMed
    Score: 0.008
  76. Regulation of transient receptor potential melastatin 4 channel by sarcoplasmic reticulum inositol trisphosphate receptors: Role in human detrusor smooth muscle function. Channels (Austin). 2017 Sep 03; 11(5):459-466.
    View in: PubMed
    Score: 0.008
  77. The UCLA surgical approach to sphincteric incontinence in women. World J Urol. 1997; 15(5):280-94.
    View in: PubMed
    Score: 0.008
  78. A three dimensional nerve map of human bladder trigone. Neurourol Urodyn. 2017 04; 36(4):1015-1019.
    View in: PubMed
    Score: 0.007
  79. BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function. Am J Physiol Renal Physiol. 2016 05 15; 310(10):F994-9.
    View in: PubMed
    Score: 0.007
  80. Novel regulatory mechanism in human urinary bladder: central role of transient receptor potential melastatin 4 channels in detrusor smooth muscle function. Am J Physiol Cell Physiol. 2016 Apr 01; 310(7):C600-11.
    View in: PubMed
    Score: 0.007
  81. Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2016 06; 35(5):595-600.
    View in: PubMed
    Score: 0.007
  82. Functional link between muscarinic receptors and large-conductance Ca2+ -activated K+ channels in freshly isolated human detrusor smooth muscle cells. Pflugers Arch. 2015 Apr; 467(4):665-75.
    View in: PubMed
    Score: 0.006
  83. Position statement on mesh midurethral slings for stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2014 May-Jun; 20(3):123-5.
    View in: PubMed
    Score: 0.006
  84. BRL37344, a ?3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels. Urology. 2013 Sep; 82(3):744.e1-7.
    View in: PubMed
    Score: 0.006
  85. Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels. PLoS One. 2013; 8(7):e68052.
    View in: PubMed
    Score: 0.006
  86. Single-channel biophysical and pharmacological characterizations of native human large-conductance calcium-activated potassium channels in freshly isolated detrusor smooth muscle cells. Pflugers Arch. 2013 Jul; 465(7):965-75.
    View in: PubMed
    Score: 0.006
  87. SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscle. Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15; 304(2):R155-63.
    View in: PubMed
    Score: 0.006
  88. Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel. Am J Physiol Renal Physiol. 2012 Nov 01; 303(9):F1300-6.
    View in: PubMed
    Score: 0.006
  89. Investigation of a Ca2+ channel a2d ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial. J Urol. 2012 Sep; 188(3):817-23.
    View in: PubMed
    Score: 0.006
  90. SK but not IK channels regulate human detrusor smooth muscle spontaneous and nerve-evoked contractions. Am J Physiol Renal Physiol. 2012 Aug 15; 303(4):F559-68.
    View in: PubMed
    Score: 0.006
  91. Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1599-608.
    View in: PubMed
    Score: 0.006
  92. Suppression of human detrusor smooth muscle excitability and contractility via pharmacological activation of large conductance Ca2+-activated K+ channels. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1632-41.
    View in: PubMed
    Score: 0.006
  93. Large-conductance voltage- and Ca2+-activated K+ channels regulate human detrusor smooth muscle function. Am J Physiol Cell Physiol. 2011 Oct; 301(4):C903-12.
    View in: PubMed
    Score: 0.005
  94. Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials. Drugs Aging. 2011 Feb 01; 28(2):151-60.
    View in: PubMed
    Score: 0.005
  95. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged = 75 years) with overactive bladder syndrome. BJU Int. 2011 Feb; 107(4):612-20.
    View in: PubMed
    Score: 0.005
  96. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010 May; 183(5):1906-14.
    View in: PubMed
    Score: 0.005
  97. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010 Jan; 183(1):234-40.
    View in: PubMed
    Score: 0.005
  98. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010 May; 105(9):1276-82.
    View in: PubMed
    Score: 0.005
  99. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75.
    View in: PubMed
    Score: 0.005
  100. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009 Oct; 74(4):771-5.
    View in: PubMed
    Score: 0.005
  101. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 Sep; 182(3):1055-61.
    View in: PubMed
    Score: 0.005
  102. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008 May; 179(5):1850-6.
    View in: PubMed
    Score: 0.004
  103. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43.
    View in: PubMed
    Score: 0.004
  104. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007 Feb; 177(2):556-60.
    View in: PubMed
    Score: 0.004
  105. MRI of endocervicosis: an unusual cause of clustered periurethral cystic masses involving the bladder. AJR Am J Roentgenol. 2007 Feb; 188(2):W147-9.
    View in: PubMed
    Score: 0.004
  106. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006 Apr; 67(4):731-6; discussion 736.
    View in: PubMed
    Score: 0.004
  107. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005 Nov-Dec; 8 Suppl 1:S25-34.
    View in: PubMed
    Score: 0.004
  108. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005 Jan; 173(1):93-7.
    View in: PubMed
    Score: 0.003
  109. A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol. 2005 Jan; 192(1):66-73.
    View in: PubMed
    Score: 0.003
  110. Is urine methylhistamine a useful marker for interstitial cystitis? J Urol. 2004 Dec; 172(6 Pt 1):2256-60.
    View in: PubMed
    Score: 0.003
  111. Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis. Urology. 2003 May; 61(5):897-901.
    View in: PubMed
    Score: 0.003
  112. Endoluminal magnetic resonance imaging in the evaluation of urethral diverticula in women. Urology. 2001 Apr; 57(4):660-5.
    View in: PubMed
    Score: 0.003
  113. Simultaneous upper and lower urinary tract obstruction associated with severe genital prolapse: diagnosis and evaluation with magnetic resonance imaging. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(2):144-6.
    View in: PubMed
    Score: 0.003
  114. Colonic polyp in a urinary diversion causing hematuria: diagnosis on ultrasonography. J Ultrasound Med. 2000 Nov; 19(11):797-9.
    View in: PubMed
    Score: 0.003
  115. Continence mechanism based on a modified ileocecal valve. Tech Urol. 2000 Sep; 6(3):167-71.
    View in: PubMed
    Score: 0.002
  116. 4-Defect repair of grade 4 cystocele. J Urol. 1999 Feb; 161(2):587-94.
    View in: PubMed
    Score: 0.002
  117. Posthysterectomy vaginal cuff fistula: diagnosis and management of an unusual cause of "incontinence". Urology. 1998 Jul; 52(1):61-4; discussion 64-5.
    View in: PubMed
    Score: 0.002
  118. Vaginal evisceration. Urology. 1998 Jan; 51(1):128-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.